Skip to main content
Top
Published in: The journal of nutrition, health & aging 4/2017

01-04-2017

Effect of a low glycemic index Mediterranean diet on non-alcoholic fatty liver disease. A randomized controlled clinici trial

Authors: G. Misciagna, M. del Pilar Díaz, D. V. Caramia, C. Bonfiglio, I. Franco, M. R. Noviello, M. Chiloiro, D. I. Abbrescia, A. Mirizzi, M. Tanzi, M. G. Caruso, M. Correale, R. Reddavide, R. Inguaggiato, A. M. Cisternino, Alberto Rubén Osella

Published in: The journal of nutrition, health & aging | Issue 4/2017

Login to get access

Abstract

Introduction

Non-Alcoholic Fatty Liver Disease (NAFLD) is currently the most common form of liver disease worldwide affecting all ages and ethnic groups and it has become a consistent threat even in young people. Our aim was to estimate the effect of a Low Glycemic Index Mediterranean Diet (LGIMD) on the NAFLD score as measured by a Liver Ultrasonography (LUS).

Design

NUTRIzione in EPAtologia (NUTRIEPA) is a population-based Double-Blind RCT. Data were collected in 2011 and analyzed in 2013-14.

Setting/participants

98 men and women coming from Putignano (Puglia, Southern Italy) were drawn from a previous randomly sampled population-based study and identified as having moderate or severe NAFLD.

Intervention

The intervention strategy was the assignment of a LGIMD or a control diet.

Outcome measures

The main outcome measure was NAFLD score, defined by LUS.

Results

After randomization, 50 subjects were assigned to a LGIMD and 48 to a control diet. The study lasted six months and all participants were subject to monthly controls/checks. Adherence to the LGIMD as measured by Mediterranean Adequacy Index (MAI) showed a median of 10.1. A negative interaction between time and LGIMD on the NAFLD score (-4.14, 95% CI -6.78,-1.49) was observed, and became more evident at the sixth month (-4.43, 95%CI -7.15, -1.71). A positive effect of the interaction among LGIMD, time and age (Third month: 0.07, 95% CI 0.02, 0.12; Sixth month: 0.08, 95% CI 0.03,0.13) was also observed.

Conclusions

LGIMD was found to decrease the NAFLD score in a relatively short time. Encouraging those subjects who do not seek medical attention but still have NAFLD to follow a LGIMD and other life-style interventions, may reduce the degree of severity of the disease. Dietary intervention of this kind, could also form the cornerstone of primary prevention of Type 2 Diabetes Mellitus (T2DM) and cardiovascular disease.
Literature
1.
go back to reference Loria P, Adinolfi LE, Bellentani S, et al. Practice guidelines for the diagnosis and management of nonalcoholic fatty liver disease. A Decalogue from the Italian Association for the Study of the Liver (AISF) Expert Committee. Dig Liver Dis 2010; 42: 272–282.http://dx.doi.org/10.1016/j.dld.2010.01.021 Loria P, Adinolfi LE, Bellentani S, et al. Practice guidelines for the diagnosis and management of nonalcoholic fatty liver disease. A Decalogue from the Italian Association for the Study of the Liver (AISF) Expert Committee. Dig Liver Dis 2010; 42: 272–282.http://​dx.​doi.​org/​10.​1016/​j.​dld.​2010.​01.​021
2.
go back to reference Bedogni G, Miglioli L, Masutti F, et al. Prevalence of and risk factors for nonalcoholic fatty liver disease: the Dionysos nutrition and liver study. Hepatology 2005:42,44–52.http://dx.doi.org/10.1002/hep.20734CrossRefPubMed Bedogni G, Miglioli L, Masutti F, et al. Prevalence of and risk factors for nonalcoholic fatty liver disease: the Dionysos nutrition and liver study. Hepatology 2005:42,44–52.http://​dx.​doi.​org/​10.​1002/​hep.​20734CrossRefPubMed
3.
go back to reference Kotronen A, Juurinen L, Hakkarainen A, et al. Liver fat is increased in type 2 diabetes patients and underestimated by serum alanine aminotransferase compared with equally obese nondiabetic subjects. Diabetes Care 2008; 31: 165–169.http://dx.doi.org/10.2337/dc07-1463CrossRefPubMed Kotronen A, Juurinen L, Hakkarainen A, et al. Liver fat is increased in type 2 diabetes patients and underestimated by serum alanine aminotransferase compared with equally obese nondiabetic subjects. Diabetes Care 2008; 31: 165–169.http://​dx.​doi.​org/​10.​2337/​dc07-1463CrossRefPubMed
4.
go back to reference Zoppini G, Fedeli U, Gennaro N, et al. Mortality from chronic liver diseases in diabetes. Am J Gastroenterol 2014; 109: 1020–1025. http://dx.doi.org/10.1038/ajg.2014.132CrossRefPubMed Zoppini G, Fedeli U, Gennaro N, et al. Mortality from chronic liver diseases in diabetes. Am J Gastroenterol 2014; 109: 1020–1025. http://​dx.​doi.​org/​10.​1038/​ajg.​2014.​132CrossRefPubMed
5.
go back to reference Angelico F, Del Ben M, Conti R, et al. Insulin resistance, the metabolic syndrome, and nonalcoholic fatty liver disease. J Clin Endocrinol Metab 2005; 90: 1578–1582. http://dx.doi.org/10.1210/jc.2004-1024CrossRefPubMed Angelico F, Del Ben M, Conti R, et al. Insulin resistance, the metabolic syndrome, and nonalcoholic fatty liver disease. J Clin Endocrinol Metab 2005; 90: 1578–1582. http://​dx.​doi.​org/​10.​1210/​jc.​2004-1024CrossRefPubMed
6.
go back to reference Charlton MR, Burns JM, Pedersen RA, et al. Frequency and outcomes of liver transplantation for nonalcoholic steatohepatitis in the United States. Gastroenterology 2011; 141: 1249–1253.http://dx.doi.org/10.1053/j.gastro.2011.06.061CrossRefPubMed Charlton MR, Burns JM, Pedersen RA, et al. Frequency and outcomes of liver transplantation for nonalcoholic steatohepatitis in the United States. Gastroenterology 2011; 141: 1249–1253.http://​dx.​doi.​org/​10.​1053/​j.​gastro.​2011.​06.​061CrossRefPubMed
7.
go back to reference Mahady SE & George J. Management of Nonalcoholic Steatohepatitis. Clin Liver Dis 2012; 16: 631–645. http://dx.doi.org/10.1016/j.cld.2012.05.003CrossRefPubMed Mahady SE & George J. Management of Nonalcoholic Steatohepatitis. Clin Liver Dis 2012; 16: 631–645. http://​dx.​doi.​org/​10.​1016/​j.​cld.​2012.​05.​003CrossRefPubMed
8.
go back to reference Sofi F, Abbate R, Gensini GF, et al. Accruing evidence on benefits of adherence to the Mediterranean diet on health: an updated systematic review and meta-analysis. Am J Clin Nutr 2010; 92: 1189–1196.http://dx.doi.org/10.3945/ajcn.2010.29673CrossRefPubMed Sofi F, Abbate R, Gensini GF, et al. Accruing evidence on benefits of adherence to the Mediterranean diet on health: an updated systematic review and meta-analysis. Am J Clin Nutr 2010; 92: 1189–1196.http://​dx.​doi.​org/​10.​3945/​ajcn.​2010.​29673CrossRefPubMed
9.
go back to reference Galbete C, Toledo E, Toledo JB, et al. Mediterranean diet and cognitive function: the SUN project. J Nutr Health Aging 2015; 19: 305–312. http://dx.doi.org/10.1007/s12603-015-0441-zCrossRefPubMed Galbete C, Toledo E, Toledo JB, et al. Mediterranean diet and cognitive function: the SUN project. J Nutr Health Aging 2015; 19: 305–312. http://​dx.​doi.​org/​10.​1007/​s12603-015-0441-zCrossRefPubMed
10.
go back to reference Kontogianni MD, Tileli N, Margariti A, et al. Adherence to the Mediterranean diet is associated with the severity of non-alcoholic fatty liver disease. Clin Nutr 2014; 33: 678–683.http://dx.doi.org/10.1016/j.clnu.2013.08.014CrossRefPubMed Kontogianni MD, Tileli N, Margariti A, et al. Adherence to the Mediterranean diet is associated with the severity of non-alcoholic fatty liver disease. Clin Nutr 2014; 33: 678–683.http://​dx.​doi.​org/​10.​1016/​j.​clnu.​2013.​08.​014CrossRefPubMed
11.
go back to reference Estruch R, Ros E, Salas-Salvadó J, et al. Primary prevention of cardiovascular disease with a Mediterranean diet. N Engl J Med 2013; 368: 1279–1290.http://dx.doi.org/10.1056/NEJMoa1200303CrossRefPubMed Estruch R, Ros E, Salas-Salvadó J, et al. Primary prevention of cardiovascular disease with a Mediterranean diet. N Engl J Med 2013; 368: 1279–1290.http://​dx.​doi.​org/​10.​1056/​NEJMoa1200303CrossRefPubMed
12.
go back to reference Kastorini CM, Milionis HJ, Esposito K, et al. The effect of Mediterranean diet on metabolic syndrome and its components: a meta-analysis of 50 studies and 534,906 individuals. J Am Coll Cardiol 2011; 57: 1299–1313.http://dx.doi.org/10.1016/j.jacc.2010.09.073CrossRefPubMed Kastorini CM, Milionis HJ, Esposito K, et al. The effect of Mediterranean diet on metabolic syndrome and its components: a meta-analysis of 50 studies and 534,906 individuals. J Am Coll Cardiol 2011; 57: 1299–1313.http://​dx.​doi.​org/​10.​1016/​j.​jacc.​2010.​09.​073CrossRefPubMed
13.
go back to reference Salas-Salvadó J, Bulló M, Babio N, et al. Reduction in the incidence of type 2 diabetes with the Mediterranean diet: results of the PREDIMED-Reus nutrition intervention randomized trial. Diabetes Care 2011; 34: 14–19.http://dx.doi.org/10.2337/dc10-1288CrossRefPubMed Salas-Salvadó J, Bulló M, Babio N, et al. Reduction in the incidence of type 2 diabetes with the Mediterranean diet: results of the PREDIMED-Reus nutrition intervention randomized trial. Diabetes Care 2011; 34: 14–19.http://​dx.​doi.​org/​10.​2337/​dc10-1288CrossRefPubMed
14.
go back to reference Cozzolongo R, Osella AR, Elba S, et al. Epidemiology of HCV infection in the general population: a survey in a southern Italian town. Am J Gastroenterol 2009; 104: 2740–2746.http://dx.doi.org/10.1038/ajg.2009.428CrossRefPubMed Cozzolongo R, Osella AR, Elba S, et al. Epidemiology of HCV infection in the general population: a survey in a southern Italian town. Am J Gastroenterol 2009; 104: 2740–2746.http://​dx.​doi.​org/​10.​1038/​ajg.​2009.​428CrossRefPubMed
15.
go back to reference Nestle M. Mediterranean diets: historical and research overview. Am J Clin Nutr 1995;61:Suppl, S1313–S1320. Nestle M. Mediterranean diets: historical and research overview. Am J Clin Nutr 1995;61:Suppl, S1313–S1320.
16.
go back to reference Chiloiro M, Caruso MG, Cisternino AM, et al. Ultrasound evaluation and correlates of fatty liver disease: A population Study in a Mediterranean Area. Metab Syndr Relat Disord 2013; 11: 349–358.http://dx.doi.org/10.1089/met.2012.0169CrossRefPubMed Chiloiro M, Caruso MG, Cisternino AM, et al. Ultrasound evaluation and correlates of fatty liver disease: A population Study in a Mediterranean Area. Metab Syndr Relat Disord 2013; 11: 349–358.http://​dx.​doi.​org/​10.​1089/​met.​2012.​0169CrossRefPubMed
17.
go back to reference Skinner HA & Sheu WJ. Reliability of alcohol use indices. The Lifetime Drinking History and the MAST. J Stud Alcohol 1982; 43: 1157–1170.PubMed Skinner HA & Sheu WJ. Reliability of alcohol use indices. The Lifetime Drinking History and the MAST. J Stud Alcohol 1982; 43: 1157–1170.PubMed
18.
go back to reference Chiloiro M, Misciagna G. (2012) Ultrasonographic Anthropometry: An Application to the Measurement of Liver and Abdominal Fat. In: Preedy VR, ed. Handbook of Anthropometry, Physical Measures of Human Form in Health and Disease. New York: Springer, pp 2227–2242. Chiloiro M, Misciagna G. (2012) Ultrasonographic Anthropometry: An Application to the Measurement of Liver and Abdominal Fat. In: Preedy VR, ed. Handbook of Anthropometry, Physical Measures of Human Form in Health and Disease. New York: Springer, pp 2227–2242.
19.
go back to reference INRAN (2003). Linee Guida per una sana alimentazione italiana. http://nut.entecra. it/649/Introduzione.html (accessed November 2013). INRAN (2003). Linee Guida per una sana alimentazione italiana. http://​nut.​entecra.​ it/649/Introduzione.html (accessed November 2013).
20.
go back to reference Alberti-Fidanza A, Fidanza F. Mediterranean Adequacy Index of Italian diets. Public Health Nutrition 2004; 7: 937–941.http://dx.doi.org/10.1079/PHN2004557CrossRefPubMed Alberti-Fidanza A, Fidanza F. Mediterranean Adequacy Index of Italian diets. Public Health Nutrition 2004; 7: 937–941.http://​dx.​doi.​org/​10.​1079/​PHN2004557CrossRefPubMed
21.
go back to reference Oakes JM, Rossi PH. The measurement of SES in health research: current practice and steps toward a new approach. Soc Sci Med 2003; 56: 769–784.http://dx.doi. org/10.1016/S0277-9536(02)00073-4CrossRefPubMed Oakes JM, Rossi PH. The measurement of SES in health research: current practice and steps toward a new approach. Soc Sci Med 2003; 56: 769–784.http://​dx.​doi.​ org/10.1016/S0277-9536(02)00073-4CrossRefPubMed
22.
go back to reference Bedogni G, Bellentani S, Miglioli L, et al. The Fatty Liver Index: a simple and accurate predictor of hepatic steatosis in the general population. BMC Gastroenterology 2006;6:33 http://dx.doi.org/10.1186/1471-230X-6-33CrossRefPubMedPubMedCentral Bedogni G, Bellentani S, Miglioli L, et al. The Fatty Liver Index: a simple and accurate predictor of hepatic steatosis in the general population. BMC Gastroenterology 2006;6:33 http://​dx.​doi.​org/​10.​1186/​1471-230X-6-33CrossRefPubMedPubMedCentral
23.
go back to reference Liang KY, Zeger SL. Longitudinal data analysis using generalized linear models. Biometrika 1986;73:13–22.CrossRef Liang KY, Zeger SL. Longitudinal data analysis using generalized linear models. Biometrika 1986;73:13–22.CrossRef
24.
go back to reference Hamaguchi M, Kojima T, Takeda N, et al. The metabolic syndrome as a predictor of nonalcoholic fatty liver disease. Ann Intern Med 2005; 143: 722–728.http://dx.doi. org/10.7326/0003-4819-143-10-200511150-00009CrossRefPubMed Hamaguchi M, Kojima T, Takeda N, et al. The metabolic syndrome as a predictor of nonalcoholic fatty liver disease. Ann Intern Med 2005; 143: 722–728.http://​dx.​doi.​ org/10.7326/0003-4819-143-10-200511150-00009CrossRefPubMed
25.
go back to reference Bedogni G, Bellentani S. Fatty liver disease: how frequent is it and why? Ann Hepatol 2004; 3: 63–65.PubMed Bedogni G, Bellentani S. Fatty liver disease: how frequent is it and why? Ann Hepatol 2004; 3: 63–65.PubMed
26.
go back to reference Marchesini G, Brizi M, Morselli-Labate AM, et al. Association of nonalcoholic fatty liver disease with insulin resistance. Am J Med 1999; 107: 450–455.http://dx.doi. org/10.1016/S0002-9343(99)00271-5CrossRefPubMed Marchesini G, Brizi M, Morselli-Labate AM, et al. Association of nonalcoholic fatty liver disease with insulin resistance. Am J Med 1999; 107: 450–455.http://​dx.​doi.​ org/10.1016/S0002-9343(99)00271-5CrossRefPubMed
27.
go back to reference Shah K, Stufflebam A, Hilton TN, et al. Diet and exercise interventions reduce intrahepatic fat content and improve insulin sensitivity in obese older adults. Obesity 2009; 17: 2162–2168.http://dx.doi.org/10.1038/oby.2009.126CrossRefPubMedPubMedCentral Shah K, Stufflebam A, Hilton TN, et al. Diet and exercise interventions reduce intrahepatic fat content and improve insulin sensitivity in obese older adults. Obesity 2009; 17: 2162–2168.http://​dx.​doi.​org/​10.​1038/​oby.​2009.​126CrossRefPubMedPubMedCentral
28.
go back to reference Luyckx FH, Desaive C, Thiry A, et al. Liver abnormalities in severely obese subjects: effect of drastic weight loss after gastroplasty. Int J Obes Relat Metab Disord 1998; 22: 222–226.CrossRefPubMed Luyckx FH, Desaive C, Thiry A, et al. Liver abnormalities in severely obese subjects: effect of drastic weight loss after gastroplasty. Int J Obes Relat Metab Disord 1998; 22: 222–226.CrossRefPubMed
29.
go back to reference Katan MB. Weight-loss diets for the prevention and treatment of obesity. N Engl J Med 2009; 360: 923–925.http://dx.doi.org/10.1056/NEJMe0810291CrossRefPubMed Katan MB. Weight-loss diets for the prevention and treatment of obesity. N Engl J Med 2009; 360: 923–925.http://​dx.​doi.​org/​10.​1056/​NEJMe0810291CrossRefPubMed
30.
go back to reference Inguaggiato R, Ferrara P. (2012) Alimenti della Dieta Mediterranea. In: Cisternino AM, Misciagna G, ed. La Dieta Mediterranea della Puglia. Bari (Italy): Tholos, pp 151–185. Inguaggiato R, Ferrara P. (2012) Alimenti della Dieta Mediterranea. In: Cisternino AM, Misciagna G, ed. La Dieta Mediterranea della Puglia. Bari (Italy): Tholos, pp 151–185.
31.
go back to reference Garg A. High-monounsaturated-fat diets for patients with diabetes mellitus: a metaanalysis. Am J Clin Nutr 1998;67:577S–582S.PubMed Garg A. High-monounsaturated-fat diets for patients with diabetes mellitus: a metaanalysis. Am J Clin Nutr 1998;67:577S–582S.PubMed
32.
go back to reference Hussein O, Grosovski M, Lasri E, et al. Monounsaturated fat decreases hepatic lipid content in non-alcoholic fatty liver disease in rats. World J Gastroenterol 2007; 13: 361–368.http://dx.doi.org/10.3748/wjg.v13.i3.361CrossRefPubMedPubMedCentral Hussein O, Grosovski M, Lasri E, et al. Monounsaturated fat decreases hepatic lipid content in non-alcoholic fatty liver disease in rats. World J Gastroenterol 2007; 13: 361–368.http://​dx.​doi.​org/​10.​3748/​wjg.​v13.​i3.​361CrossRefPubMedPubMedCentral
33.
go back to reference Storlien LH, Kraegen EW, Chisholm DJ, et al. Fish oil prevents insulin resistance induced by high-fat feeding in rats. Science 1987; 237: 885–888.http://dx.doi. org/10.1126/science.3303333CrossRefPubMed Storlien LH, Kraegen EW, Chisholm DJ, et al. Fish oil prevents insulin resistance induced by high-fat feeding in rats. Science 1987; 237: 885–888.http://​dx.​doi.​ org/10.1126/science.3303333CrossRefPubMed
34.
go back to reference Levy JR, Clore JN, Stevens W. Dietary n-3 polyunsaturated fatty acids decrease hepatic triglycerides in Fischer 344 rats. Hepatology 2004; 39: 608–616.http://dx.doi.org/10.1002/hep.20093CrossRefPubMed Levy JR, Clore JN, Stevens W. Dietary n-3 polyunsaturated fatty acids decrease hepatic triglycerides in Fischer 344 rats. Hepatology 2004; 39: 608–616.http://​dx.​doi.​org/​10.​1002/​hep.​20093CrossRefPubMed
35.
go back to reference Sekiya M, Yahagi N, Matsuzaka T, et al. Polyunsaturated fatty acids ameliorate hepatic steatosis in obese mice by SREBP-1 suppression. Hepatology 2003; 38: 1529–1539.http://dx.doi.org/10.1016/j.hep.2003.09.028CrossRefPubMed Sekiya M, Yahagi N, Matsuzaka T, et al. Polyunsaturated fatty acids ameliorate hepatic steatosis in obese mice by SREBP-1 suppression. Hepatology 2003; 38: 1529–1539.http://​dx.​doi.​org/​10.​1016/​j.​hep.​2003.​09.​028CrossRefPubMed
36.
go back to reference Cortez-Pinto H, Jesus L, Barros H, et al. How different is the dietary pattern in non-alcoholic steatohepatitis patients? Clin Nutr 2006; 25: 816–823.http://dx.doi. org/10.1016/j.clnu.2006.01.027CrossRefPubMed Cortez-Pinto H, Jesus L, Barros H, et al. How different is the dietary pattern in non-alcoholic steatohepatitis patients? Clin Nutr 2006; 25: 816–823.http://​dx.​doi.​ org/10.1016/j.clnu.2006.01.027CrossRefPubMed
37.
go back to reference Zelber-Sagi S, Nitzan-Kaluski D, Goldsmith R, et al. Long term nutritional intake and the risk for non-alcoholic fatty liver disease (NAFLD): a population based study. J Hepatol 2007; 47: 711–717. http://dx.doi.org/10.1016/j.jhep.2007.06.020CrossRefPubMed Zelber-Sagi S, Nitzan-Kaluski D, Goldsmith R, et al. Long term nutritional intake and the risk for non-alcoholic fatty liver disease (NAFLD): a population based study. J Hepatol 2007; 47: 711–717. http://​dx.​doi.​org/​10.​1016/​j.​jhep.​2007.​06.​020CrossRefPubMed
38.
go back to reference Capanni M, Calella F, Biagini MR, et al. Prolonged n-3 polyunsaturated fatty acid supplementation ameliorates hepatic steatosis in patients with non-alcoholic fatty liver disease: a pilot study. Aliment Pharmacol Ther 2006; 23: 1143–1151.http://dx.doi. org/10.1111/j.1365-2036.2006.02885.xCrossRefPubMed Capanni M, Calella F, Biagini MR, et al. Prolonged n-3 polyunsaturated fatty acid supplementation ameliorates hepatic steatosis in patients with non-alcoholic fatty liver disease: a pilot study. Aliment Pharmacol Ther 2006; 23: 1143–1151.http://​dx.​doi.​ org/10.1111/j.1365-2036.2006.02885.xCrossRefPubMed
39.
go back to reference Tanaka N, Sano K, Horiuchi A, et al. Highly purified eicosapentaenoic acid treatment improves nonalcoholic steatohepatitis. J Clin Gastroenterol 2008; 42: 413–418.http://dx.doi.org/10.1097/MCG.0b013e31815591aaCrossRefPubMed Tanaka N, Sano K, Horiuchi A, et al. Highly purified eicosapentaenoic acid treatment improves nonalcoholic steatohepatitis. J Clin Gastroenterol 2008; 42: 413–418.http://​dx.​doi.​org/​10.​1097/​MCG.​0b013e31815591aa​CrossRefPubMed
40.
go back to reference Omara-Alwala TR, Mebrahtu T, Prior DE, et al. Omega-three fatty acids in purslane (Portulaca oleracea) Tissues. J Am Oil Chem Soc 1991; 68: 198–199.http://dx.doi. org/10.1007/BF02657769CrossRef Omara-Alwala TR, Mebrahtu T, Prior DE, et al. Omega-three fatty acids in purslane (Portulaca oleracea) Tissues. J Am Oil Chem Soc 1991; 68: 198–199.http://​dx.​doi.​ org/10.1007/BF02657769CrossRef
41.
go back to reference Westerbacka J, Lammi K, Häkkinen AM, et al. Dietary fat content modifies liver fat in overweight non-diabetic subjects. J Clin Endocrinol Metab 2005; 90: 2804–2809. http://dx.doi.org/10.1210/jc.2004-1983CrossRefPubMed Westerbacka J, Lammi K, Häkkinen AM, et al. Dietary fat content modifies liver fat in overweight non-diabetic subjects. J Clin Endocrinol Metab 2005; 90: 2804–2809. http://​dx.​doi.​org/​10.​1210/​jc.​2004-1983CrossRefPubMed
42.
go back to reference van Herpen NA, Schrauwen-Hinderling VB, Schaart G, et al. Three weeks on a highfat diet increases intrahepatic lipid accumulation and decreases metabolic flexibility in healthy overweight men. J Clin Endocrinol Metab 2011;96:E691–E695.http://dx.doi.org/10.1210/jc.2010-2243CrossRefPubMed van Herpen NA, Schrauwen-Hinderling VB, Schaart G, et al. Three weeks on a highfat diet increases intrahepatic lipid accumulation and decreases metabolic flexibility in healthy overweight men. J Clin Endocrinol Metab 2011;96:E691–E695.http://​dx.​doi.​org/​10.​1210/​jc.​2010-2243CrossRefPubMed
43.
go back to reference Utzschneider KM, Bayer-Carter JL, Arbuckle MD, et al. Beneficial effect of a weight-stable, low-fat/low-saturated fat/low-glycemic index diet to reduce liver fat in older subjects. Br J Nutr 2013; 109: 1096–1104.CrossRefPubMed Utzschneider KM, Bayer-Carter JL, Arbuckle MD, et al. Beneficial effect of a weight-stable, low-fat/low-saturated fat/low-glycemic index diet to reduce liver fat in older subjects. Br J Nutr 2013; 109: 1096–1104.CrossRefPubMed
44.
go back to reference Day CP & James OF. Steatohepatitis: a tale of two “hits”? Gastroenterology 1998; 114: 842–845. http://dx.doi.org/10.1016/S0016-5085(98)70599-2 Day CP & James OF. Steatohepatitis: a tale of two “hits”? Gastroenterology 1998; 114: 842–845. http://​dx.​doi.​org/​10.​1016/​S0016-5085(98)70599-2
45.
go back to reference Alberti A, Fruttini D, Fidanza F. The Mediterranean Adequacy Index: further confirming results of validity. Nutr Metab Cardiovasc Dis 2009; 19: 61–66.http://dx.doi.org/10.1016/j.numecd.2007.11.008CrossRefPubMed Alberti A, Fruttini D, Fidanza F. The Mediterranean Adequacy Index: further confirming results of validity. Nutr Metab Cardiovasc Dis 2009; 19: 61–66.http://​dx.​doi.​org/​10.​1016/​j.​numecd.​2007.​11.​008CrossRefPubMed
46.
go back to reference Middleton G, Keegan R, Smith MF, et al. Implementing a Mediterranean Diet Intervention into an RCT: Lessons Learned from a Non-Mediterranean Based Country. J Nutr Health Aging2015; 19: 1019–1022. http://dx.doi.org/10.1007/s12603-015-0522-z. Middleton G, Keegan R, Smith MF, et al. Implementing a Mediterranean Diet Intervention into an RCT: Lessons Learned from a Non-Mediterranean Based Country. J Nutr Health Aging2015; 19: 1019–1022. http://​dx.​doi.​org/​10.​1007/​s12603-015-0522-z.​
48.
go back to reference Joy D, Thava VR, Scott B. Diagnosis of fatty liver disease: is biopsy necessary? Eur J Gastroenterol Hepatol 2003; 15: 539–543.http://dx.doi.org/10.1097/01. meg.0000059112.41030.2ePubMed Joy D, Thava VR, Scott B. Diagnosis of fatty liver disease: is biopsy necessary? Eur J Gastroenterol Hepatol 2003; 15: 539–543.http://​dx.​doi.​org/​10.​1097/​01.​ meg.0000059112.41030.2ePubMed
49.
go back to reference Wieckowska A, McCullough AJ, Feldstein AE. Noninvasive diagnosis and monitoring of nonalcoholic steatohepatitis: present and future. Hepatology 2007; 46: 582–589.http://dx.doi.org/10.1002/hep.21768CrossRefPubMed Wieckowska A, McCullough AJ, Feldstein AE. Noninvasive diagnosis and monitoring of nonalcoholic steatohepatitis: present and future. Hepatology 2007; 46: 582–589.http://​dx.​doi.​org/​10.​1002/​hep.​21768CrossRefPubMed
50.
go back to reference Saadeh S, Younossi ZM, Remer EM, et al. The utility of radiological imaging in nonalcoholic fatty liver disease. Gastroenterology 2002; 123: 745–750.http://dx.doi. org/10.1053/gast.2002.35354CrossRefPubMed Saadeh S, Younossi ZM, Remer EM, et al. The utility of radiological imaging in nonalcoholic fatty liver disease. Gastroenterology 2002; 123: 745–750.http://​dx.​doi.​ org/10.1053/gast.2002.35354CrossRefPubMed
51.
go back to reference Cameron SV & Heckman JJ. Life Cycle Schooling and Dynamic Selection Bias: Models and Evidence for Five Cohorts of American Males. The Journal of Political Economy 1998;106:262–333.CrossRef Cameron SV & Heckman JJ. Life Cycle Schooling and Dynamic Selection Bias: Models and Evidence for Five Cohorts of American Males. The Journal of Political Economy 1998;106:262–333.CrossRef
52.
go back to reference Bazzano LA, Hu T, Reynoldas K, et al. Effects of Low-Carbohydrate and Low-Fat Diets: A Randomized Trial. Ann Intern Med 2014; 161: 309–318.http://dx.doi. org/10.3390/nu7095377CrossRefPubMedPubMedCentral Bazzano LA, Hu T, Reynoldas K, et al. Effects of Low-Carbohydrate and Low-Fat Diets: A Randomized Trial. Ann Intern Med 2014; 161: 309–318.http://​dx.​doi.​ org/10.3390/nu7095377CrossRefPubMedPubMedCentral
Metadata
Title
Effect of a low glycemic index Mediterranean diet on non-alcoholic fatty liver disease. A randomized controlled clinici trial
Authors
G. Misciagna
M. del Pilar Díaz
D. V. Caramia
C. Bonfiglio
I. Franco
M. R. Noviello
M. Chiloiro
D. I. Abbrescia
A. Mirizzi
M. Tanzi
M. G. Caruso
M. Correale
R. Reddavide
R. Inguaggiato
A. M. Cisternino
Alberto Rubén Osella
Publication date
01-04-2017
Publisher
Springer Paris
Published in
The journal of nutrition, health & aging / Issue 4/2017
Print ISSN: 1279-7707
Electronic ISSN: 1760-4788
DOI
https://doi.org/10.1007/s12603-016-0809-8

Other articles of this Issue 4/2017

The journal of nutrition, health & aging 4/2017 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.